Financials data is unavailable for this security.
View more
Year on year Phibro Animal Health Corp had net income fall -92.59% from 32.61m to 2.42m despite revenues that grew 4.07% from 977.89m to 1.02bn over the same period.
| Gross margin | 31.47% |
|---|---|
| Net profit margin | 1.66% |
| Operating margin | 6.85% |
| Return on assets | 1.80% |
|---|---|
| Return on equity | 6.55% |
| Return on investment | 2.20% |
More ▼
Cash flow in USDView more
In 2024, Phibro Animal Health Corp increased its cash reserves by 71.05%, or 29.33m. The company earned 87.59m from its operations for a Cash Flow Margin of 8.61%. In addition the company used 48.19m on investing activities and also paid 6.77m in financing cash flows.
| Cash flow per share | 1.32 |
|---|---|
| Price/Cash flow per share | 17.98 |
| Book value per share | 6.38 |
|---|---|
| Tangible book value per share | 3.98 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.23 |
|---|---|
| Quick ratio | 1.69 |
| Total debt/total equity | 1.83 |
|---|---|
| Total debt/total capital | 0.6472 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -92.59%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
| Div yield(5 year avg) | 2.29% |
|---|---|
| Div growth rate (5 year) | 0.85% |
| Payout ratio (TTM) | 111.70% |
| EPS growth(5 years) | -46.35 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -16.14 |
More ▼
